Phase I Trial in Participants with Rheumatoid Arthritis and Healthy Volunteers with CIT-013, a First in Class NETosis Inhibitor

CIT-013 - Citryll

Maarten Kraan1; Salah Hadi2; Leonie Middelink3; Renato Chirivi3; Eric meldrum3; Naomi Klarenbeek4; Patrick Round3

Sep 15, 2025